In statin-intolerant adults with, or at risk for, CV disease, bempedoic acid reduced MACE at a median 41 mo

Annals of Internal Medicine（2023）

引用 0|浏览4

暂无评分

摘要

Source Citation Nissen SE, Lincoff MA, Brennan D, et al; CLEAR Outcomes Investigators. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med. 2023;388:1353-1364. 36876740

查看译文

关键词

bempedoic acid,cv disease,mace,statin-intolerant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要